Marcel Trefny

20PUBLICATIONS
119CO-AUTHORS
Molecular targetsMetabolic medicineHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 05, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|Feb 11, 2026
Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.

Janina Dörr, Lisa Gregor, Sebastian B Lacher

|Jun 26, 2025
Metabolites as agents and targets for cancer immunotherapy.

Marcel P Trefny, Guido Kroemer, Laurence Zitvogel

|Apr 03, 2025
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma.

Adrian Gottschlich, Ruth Grünmeier, Gordon Victor Hoffmann

|Nov 17, 2024
Inhibition of Cbl-b restores effector functions of human intratumoral NK cells.

Sofia Tundo, Marcel Trefny, Andrijana Rodić

|May 20, 2024
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies.

Christina Angeliki Tsiverioti, Adrian Gottschlich, Marcel Trefny

Pageof 4

Frequent Collaborators

10 joint publications

Alfred Zippelius

6 joint publications

Heinz Läubli

5 joint publications

Nicole Kirchhammer

5 joint publications

Priska Auf der Maur